UniProt ID | FBX7_HUMAN | |
---|---|---|
UniProt AC | Q9Y3I1 | |
Protein Name | F-box only protein 7 | |
Gene Name | FBXO7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 522 | |
Subcellular Localization | Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria. | |
Protein Description | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes BIRC2 and DLGAP5. Plays a role downstream of PINK1 in the clearance of damaged mitochondria via selective autophagy (mitophagy) by targeting PRKN to dysfunctional depolarized mitochondria. Promotes MFN1 ubiquitination.. | |
Protein Sequence | MRLRVRLLKRTWPLEVPETEPTLGHLRSHLRQSLLCTWGYSSNTRFTITLNYKDPLTGDEETLASYGIVSGDLICLILQDDIPAPNIPSSTDSEHSSLQNNEQPSLATSSNQTSMQDEQPSDSFQGQAAQSGVWNDDSMLGPSQNFEAESIQDNAHMAEGTGFYPSEPMLCSESVEGQVPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVLPLELKLRIFRLLDVRSVLSLSAVCRDLFTASNDPLLWRFLYLRDFRDNTVRVQDTDWKELYRKRHIQRKESPKGRFVMLLPSSTHTIPFYPNPLHPRPFPSSRLPPGIIGGEYDQRPTLPYVGDPISSLIPGPGETPSQFPPLRPRFDPVGPLPGPNPILPGRGGPNDRFPFRPSRGRPTDGRLSFM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | RVRLLKRTWPLEVPE HHEHHHCCCCCCCCC | 29.82 | 26270265 | |
28 | Phosphorylation | PTLGHLRSHLRQSLL CCHHHHHHHHHHHHH | 32.98 | 29759185 | |
33 | Phosphorylation | LRSHLRQSLLCTWGY HHHHHHHHHHHCCCC | 19.51 | 25072903 | |
37 | Phosphorylation | LRQSLLCTWGYSSNT HHHHHHHCCCCCCCC | 23.15 | 25072903 | |
40 | Phosphorylation | SLLCTWGYSSNTRFT HHHHCCCCCCCCEEE | 10.65 | 25072903 | |
41 | Phosphorylation | LLCTWGYSSNTRFTI HHHCCCCCCCCEEEE | 17.11 | 25072903 | |
42 | Phosphorylation | LCTWGYSSNTRFTIT HHCCCCCCCCEEEEE | 33.46 | 25072903 | |
44 | Phosphorylation | TWGYSSNTRFTITLN CCCCCCCCEEEEEEE | 29.16 | 25072903 | |
113 | Ubiquitination | LATSSNQTSMQDEQP CCCCCCCCCCCCCCC | 30.34 | 29967540 | |
148 | Ubiquitination | GPSQNFEAESIQDNA CCCCCCCCHHHHHCC | 16.23 | 29967540 | |
153 | Ubiquitination | FEAESIQDNAHMAEG CCCHHHHHCCCCCCC | 53.25 | 21890473 | |
173 | Ubiquitination | SEPMLCSESVEGQVP CCCCCCCCCCCCCCC | 58.78 | 29967540 | |
175 | Ubiquitination | PMLCSESVEGQVPHS CCCCCCCCCCCCCCC | 9.34 | 29967540 | |
195 | Ubiquitination | QSADCSDANDALIVL HCCCCCCHHHHHHHH | 10.25 | 21890473 | |
208 | Ubiquitination | VLIHLLMLESGYIPQ HHHHHHHHHCCCCCC | 4.83 | 29967540 | |
210 | Ubiquitination | IHLLMLESGYIPQGT HHHHHHHCCCCCCCC | 32.70 | 29967540 | |
227 | Ubiquitination | KALSMPEKWKLSGVY HHCCCCCHHCCCCEE | 43.70 | 29967540 | |
230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
230 | Ubiquitination | SMPEKWKLSGVYKLQ CCCCHHCCCCEEEEE | 5.38 | 21890473 | |
237 | Ubiquitination | LSGVYKLQYMHPLCE CCCEEEEEECCCCCC | 29.38 | 21890473 | |
279 | Ubiquitination | RSVKRLQLLPESFIC HHCCEEEECCHHHCC | 11.59 | 21890473 | |
283 | Phosphorylation | RLQLLPESFICKEKL EEEECCHHHCCHHHH | 20.26 | - | |
286 | S-nitrosylation | LLPESFICKEKLGEN ECCHHHCCHHHHCCC | 4.36 | 19483679 | |
286 | S-nitrosocysteine | LLPESFICKEKLGEN ECCHHHCCHHHHCCC | 4.36 | - | |
287 | Ubiquitination | LPESFICKEKLGENV CCHHHCCHHHHCCCH | 53.74 | 29967540 | |
289 | Ubiquitination | ESFICKEKLGENVAN HHHCCHHHHCCCHHH | 47.49 | 29967540 | |
289 | Acetylation | ESFICKEKLGENVAN HHHCCHHHHCCCHHH | 47.49 | 25953088 | |
305 | Phosphorylation | YKDLQKLSRLFKDQL HHHHHHHHHHHHHHC | 33.69 | 21955146 | |
309 | Ubiquitination | QKLSRLFKDQLVYPL HHHHHHHHHHCHHHH | 49.51 | 21890473 | |
314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
314 | Ubiquitination | LFKDQLVYPLLAFTR HHHHHCHHHHHHHHH | 9.21 | 21890473 | |
384 | Phosphorylation | LRDFRDNTVRVQDTD HHHCCCCEEEEECCC | 17.61 | - | |
393 | Ubiquitination | RVQDTDWKELYRKRH EEECCCHHHHHHHHH | 40.42 | 21906983 | |
417 | O-linked_Glycosylation | RFVMLLPSSTHTIPF CEEEECCCCCCCCCC | 48.08 | 30059200 | |
421 | O-linked_Glycosylation | LLPSSTHTIPFYPNP ECCCCCCCCCCCCCC | 30.36 | 30059200 | |
432 | Methylation | YPNPLHPRPFPSSRL CCCCCCCCCCCHHCC | 34.44 | - | |
451 | Methylation | IGGEYDQRPTLPYVG CCCCCCCCCCCCCCC | 24.23 | - | |
479 | Methylation | PSQFPPLRPRFDPVG CCCCCCCCCCCCCCC | 26.56 | - | |
481 | Methylation | QFPPLRPRFDPVGPL CCCCCCCCCCCCCCC | 42.01 | - | |
498 | Methylation | PNPILPGRGGPNDRF CCCCCCCCCCCCCCC | 44.98 | - | |
504 | Methylation | GRGGPNDRFPFRPSR CCCCCCCCCCCCCCC | 48.02 | - | |
518 | Methylation | RGRPTDGRLSFM--- CCCCCCCCCCCC--- | 29.93 | - | |
518 | Asymmetric dimethylarginine | RGRPTDGRLSFM--- CCCCCCCCCCCC--- | 29.93 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBX7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBX7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBX7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
260300 | Parkinson disease 15 (PARK15) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...